Tuesday, June 2, 2026

Daily Docket: Suboxone as Talc and Depo-Provera Expand

We tracked 115 new filings yesterday, driven by robust activity across mature pharmaceutical mass torts and rapidly expanding women's health dockets.

ASK Law submitted 23 claims into the Suboxone Film Products Liability Litigation (MDL 3092), alleging the opioid treatment causes dental erosion, as the court pushes to finalize the core discovery pool this July. The Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation (MDL 2738), alleging the products cause ovarian cancer, expanded by 14 suits, led by Ashcraft Gerel LLP with five filings, while parties navigate high-stakes settlement mediation before Judge Shipp. Volume grew in the Depo-Provera Products Liability Litigation (MDL 3140), alleging the contraceptive causes meningiomas, adding 12 new actions brought by MCH Law PLLC ahead of critical Daubert hearings scheduled later this month. Additionally, Dicello Levitt LLP initiated 12 suits in the Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator Products Liability Litigation (MDL 3014), alleging the sleep devices cause respiratory injuries, where settlement disbursements face lien resolution delays.

Rounding out the top five, emerging weight-loss drug dockets advanced as Morgan & Morgan PA contributed four claims to the Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability (Gastroparesis) Litigation (MDL 3094), alleging the injectables cause stomach paralysis as the docket builds toward late-2026 bellwethers.

Practitioner Note: The impending late-June Daubert hearings in the Depo-Provera docket represent an inflection point for the accelerating litigation. With over 5,500 claims pending and a December bellwether trial scheduled, survival of plaintiffs' general causation experts will likely trigger a massive surge in subsequent filings. Defense teams navigating mature dockets like Suboxone and J&J Talc must simultaneously adapt to fast-paced discovery pools and intensified mediation directives, signaling an aggressive mid-year federal tort landscape.

Regulators Scrutinize Discord Over Child Exploitation Safeguards

Fallout from the Texas Attorney General's late-May enforcement action against Discord continued to reverberate this week, sharpening the escalating legal threat over youth exploitation. After suing the company on May 22 and securing an emergency Temporary Restraining Order announced May 29 — which forced the messaging app to restrict its default communication and friend-request settings for Texas users — the state heads toward a June 5 hearing on its bid for a temporary injunction. The enforcement push parallels a surging wave of private personal injury and product liability lawsuits alleging that the platform's architecture facilitates predatory grooming and commercial sexual exploitation. For plaintiffs' attorneys navigating the complex tech-liability landscape, these aggressive state-level interventions provide crucial momentum to bypass Section 230 defenses by targeting defective product design rather than user-generated content. The intensified focus on Discord highlights a strategic expansion of liability theories aimed directly at the structural mechanics of digital communication tools.

Vermont Finalizes Landmark Ban of Paraquat Amid Escalating MDL Filings

On June 1, 2026, Vermont became the first U.S. state to finalize a ban on the herbicide paraquat, as Governor Phil Scott signed H.739 to fully prohibit its sale and use by 2030 — a critical regulatory flashpoint in the ongoing national debate over the chemical's link to Parkinson's disease. The state-level prohibition aligns with mounting pressure from advocates who point to bans in dozens of other countries, underscoring the severe public health risks associated with agricultural exposure. This regulatory milestone coincides with continued procedural momentum in the Paraquat Products Liability Litigation, MDL 3004, before Judge Nancy J. Rosenstengel in the Southern District of Illinois, where recent Case Management Orders 23 and 24 have governed settlement disclosures, eligible-claimant tracking, and voluntary dismissals. For plaintiffs' attorneys, the Vermont ban provides a powerful regulatory anchor that bolsters failure-to-warn and design defect claims against manufacturers. As the multidistrict litigation continues to consolidate thousands of claims, this legislative action significantly amplifies the legal and public relations pressure on the pesticide industry.